• 1
    Princen HMG, Post SM, Twisk J. Regulation of bile acid biosynthesis. Curr Pharm Des 1997; 3: 5984.
  • 2
    Chiang JYL. Regulation of bile acid synthesis. Front Biosci 1998; 3: D176D193.
  • 3
    Vlahcevic ZR, Pandak WM, Stravitz RT. Regulation of bile acid biosynthesis. Gastroenterol Clin North Am 1999; 28: 125.
  • 4
    Björkhem I. Mechanism of degradation of the steroid side chain in the formation of bile acids. J Lipid Res 1992; 33: 455472.
  • 5
    Javitt NB. Bile acid synthesis from cholesterol:regulatory and auxiliary pathways. FASEB J 1994; 8: 13081311.
  • 6
    Reihnér E, Björkhem I, Angelin B, Ewerth S, Einarsson K. Bile acid synthesis in humans: regulation of hepatic microsomal cholesterol 7α-hydroxylase activity. Gastroenterology 1989; 97: 14981505.
  • 7
    Bertolotti M, Abate N, Loria P, Dilengite M, Carubbi F, Pinetti A, Digrisolo A, et al. Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7α-hydroxylation rates in vivo. Hepatology 1991; 14: 830837.
  • 8
    Repa JJ, Mangelsdorf DJ. Nuclear receptor regulation of cholesterol and bile acid metabolism. Curr Opin Biotechnol 1999; 10: 557563.
  • 9
    Russell DW. Nuclear orphan receptors control cholesterol catabolism. Cell 1999; 97: 539542.
  • 10
    Chiang JYL. Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev 2002; 23: 443463.
  • 11
    Goodwin B, Kliewer SA. Nuclear receptors. I. Nuclear receptors and bile acid homeostasis. Am J Physiol Gastrointest Liver Physiol 2002; 282: G926G931.
  • 12
    Davis RA, Hyde PM, Kuan JCW, Malone-McNeal M, Archambault-Schexnayder J. Bile acid secretion by cultured rat hepatocytes. Regulation by cholesterol availability. J Biol Chem 1983; 258: 36613667.
  • 13
    Björkhem I, Eggertsen G, Andersson U. On the mechanism of stimulation of cholesterol 7 alpha-hydroxylase by dietary cholesterol Biochim Biophys Acta 1991; 1085: 329335.
  • 14
    Kern F Jr. Normal plasma cholesterol in an 88-year-old man who eats 25 eggs a day. Mechanisms of adaptation. N Engl J Med 1991; 324: 896899.
  • 15
    Duane WC. Effects of lovastatin and dietary cholesterol on sterol homeostasis in healthy human subjects. J Clin Invest 1993; 92: 911918.
  • 16
    Grundy SM. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med 1988; 319: 2433.
  • 17
    Reihnér E, Rudling M, Ståhlberg D, Berglund L, Ewerth S, Björkhem I, Einarsson K, et al. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. N Engl J Med 1990; 323: 224228.
  • 18
    Loria P, Bertolotti M, Cassinadri MT, Dilengite MA, Bozzoli M, Carubbi F, Concari M, et al. Short-term effects of simvastatin on bile acid synthesis and bile lipid secretion in human subjects. Hepatology 1994; 19: 882888.
  • 19
    Plosker GL, McTavish D. Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolemia. Drugs 1995; 50: 334363.
  • 20
    Bertolotti M, Concari M, Loria P, Abate N, Pinetti A, Guicciardi ME, Carulli N. Effects of different phenotypes of hyperlipoproteinemia and of treatment with fibric acid derivatives on the rates of cholesterol 7α-hydroxylation in humans. Arterioscler Thromb Vasc Biol 1995; 15: 10641069.
  • 21
    Bertolotti M, Carulli N, Menozzi D, Zironi F, Digrisolo A, Pinetti A, Baldini MG. In vivo evaluation of cholesterol 7α-hydroxylation in humans: effect of disease and drug treatment. J Lipid Res 1986; 27: 12781286.
  • 22
    Del Puppo M, Galli Kienle M, Petroni ML, Crosignani A, Podda M. Serum 27-hydroxycholesterol in patients with primary biliary cirrhosis suggests alteration of cholesterol catabolism to bile acids via the acidic pathway. J Lipid Res 1998; 39: 24772482.
  • 23
    Björkhem I, Miettinen T, Reihnér E, Ewerth S, Angelin B, Einarsson K. Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J Lipid Res 1987; 28: 11371143.
  • 24
    Kempen HJ, Glatz JF, Gevers Leuven JA, van der Voort HA, Katan MB. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lipid Res 1988; 29: 11491155.
  • 25
    Angelin B, Hershon KS, Brunzell JD. Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia. Proc Natl Acad Sci U S A 1987; 84: 54345438.
  • 26
    Davis RA, Hui TY. Atherosclerosis is a liver disease of the heart. Arterioscler Thromb Vasc Biol 2001; 21: 887898.
  • 27
    Pandak WM, Heuman DM, Hylemon PB, Vlahcevic ZR. Regulation of bile acid synthesis. IV. Interrelationship between cholesterol and bile acid biosynthesis pathways. J Lipid Res 1990; 31: 7990.
  • 28
    Muraca M, Baggio G, Miconi L, Vilei MT, Martini S, Gabelli C., Belluco C., et al. Acute effects of HMG-CoA reductase inhibitors on biliary lipids in patients with interrupted enterohepatic circulation. Eur J Clin Invest 1991; 21: 204208.
  • 29
    Vanhanen H, Kesäniemi YA, Miettinen T. Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man. Metabolism 1992; 41: 588595.
  • 30
    Naoumova RP, O'Neill FH, Dunn S, Neuwirth CKY, Taylor GW, Axelson M, Thompson GR. Effect of inhibiting HMG-CoA reductase on 7α-hydroxy-4-cholesten-3-one, a marker of bile acid synthesis: contrasting findings in patients with and without prior up-regulation of the latter pathway. Eur J Clin Invest 1999; 29: 404412.
  • 31
    Bertolotti M, Carulli L, Concari M, Martella P, Loria P, Tagliafico E, Ferrari S, et al. Suppression of bile acid synthesis, but not of hepatic cholesterol 7α-hydroxylase expression, by obstructive cholestasis in humans. Hepatology 2001; 34: 234242.
  • 32
    Mazzella G, Parini P, Festi D, Bazzoli F, Aldini R, Roda A, Tonelli D, et al. Effect of simvastatin, ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in non-familial hypercholesterolemia. Hepatology 1992; 15: 10721078.
  • 33
    Duane WC. Effects of lovastatin and dietary cholesterol on bile acid kinetics and bile lipid composition in healthy male subjects. J Lipid Res 1994; 35: 501509.
  • 34
    Mitchell JC., Stone BG, Logan GM, Duane WC. Role of cholesterol synthesis in regulation of bile acid synthesis and biliary cholesterol secretion in humans. J Lipid Res 1991; 32: 11431149.
  • 35
    Pfohl M, Naoumova RP, Kim K-D, Thompson GR. Use of cholesterol precursors to assess changes in cholesterol synthesis under non—steady-state conditions. Eur J Clin Invest 1998; 28: 491496.
  • 36
    Sudhop T, Lütjohann D, Kodal A, Igel M, Tribble DL, Shah S, Perevozskaya I, et al. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 2002; 106: 19431948.
  • 37
    Ståhlberg D, Reihnér E, Rudling M, Berglund L, Einarsson K, Angelin B. Influence of bezafibrate on hepatic cholesterol metabolism in gallstone patients: reduced activity of cholesterol 7 alpha-hydroxylase. Hepatology 1995; 21: 10251030.
  • 38
    Einarsson K, Reihnér E, Björkhem I. On the saturation of the cholesterol 7α-hydroxylase in human liver microsomes. J Lipid Res 1989; 30: 14771481.
  • 39
    Peet DJ, Turley SD, Ma WM, Janowski BA, Lobaccaro J-MA, Hammer RE, Mangelsdorf DJ. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRα. Cell 1998; 93: 693704.
  • 40
    Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997; 89: 331340.